Neural tube defects (NTDs) are birth defects that can be disabling or lethal and are second only to cardiac defects in their prevalence among major human congenital malformations. Spina bifida is a NTD where the spinal cord is dysplastic, and the overlying spinal column is absent. At present, the molecular mechanisms underlying the spinal bifida development are largely unknown. In this study, we present a mouse Fkbp8 mutant that has an isolated and completely penetrant spina bifida, which is folate-and inositol-resistant. Fkbp8 mutants are not embryolethal, and they display striking features of human spina bifida including a dysplastic spinal cord, open neural canal, and disability. Loss of Fkbp8 leads to increased apoptosis in the posterior neural tube, demonstrating that in vivo FKBP8 inhibits cell death. Gene expression analysis of Fkbp8 mutants revealed a perturbation of expression of neural tube patterning genes, suggesting that endogenous FKBP8 activity establishes dorso-ventral patterning of the neural tube. These studies demonstrate that Fkbp8 is not important for embryo survival, but is essential for spinal neural tube patterning, and to block apoptosis, in the developing neural tube.
INTRODUCTION
Neural tube defects (NTDs) are common birth defects which can be associated with serious disability, whose prevalence is second only to cardiac defects among major human congenital malformations (1) . NTDs involving the spinal cord and/or vertebral arches in the thoracicolumbo-sacral region are termed spina bifida. NTDs affect approximately 324,000 births worldwide (2) and 3,000 pregnancies annually in the United States (3) . Depending on the type of spina bifida, affected infants may have significant damage to their spinal cord, spinal nerves, and vertebrae, resulting in paralysis of lower limbs and other associated defects such as hydrocephalus. Infants with spina bifida who survive are likely to have severe, life-long disabilities, and are at risk for psychosocial maladjustment (4) . Spina bifida and other NTDs pose a serious public health problem in the United States and worldwide. Therefore, understanding the cellular and molecular mechanisms underlying the etiology of these malformations is crucial as this intention could lead to novel preventive strategies and improved counseling for high risk individuals.
The etiology of spina bifida, like many NTDs, is believed to be multi-factorial, involving both genetic and environmental factors. For decades, researchers have relied upon spontaneous, teratogenic, and transgenic animal models in order to better understand the mechanisms underlying spina bifida development. Unfortunately, many of these models suffer from either incomplete phenotypic penetrance, or poor recapitulation of either the complex genetics or the phenotype observed in human spina bifida. Furthermore the spina bifida lesion seen in these models usually occur in association with various organ defects (5) whereas in human condition is often isolated. We recently identified a Fkbp8 knockout mouse that recapitulates most of the clinical features of human spina bifida. This gene belongs to a family of immunophilin proteins functioning in immunoregulation, and protein folding and trafficking (6, 7) .
FKBP8 is a 44kDa mitochondrial protein which has three tetratricopeptide repeat (TPR) motifs, which are protein-protein interaction domains that mediate physical associations between FKBP8 and its protein interactors (8) (9) (10) . The N-terminus of FKBP8 contains a peptidylprolyl cis−trans isomerase (PPIase) domain that is conserved throughout the FKBP family, and is important for FK506 binding and PPIase activity (11, 12) .
The Fkbp8 gene has been previously targeted in the mouse where a neo cassette was inserted to disrupt part of the PPIase and TPR domains (13) . Homozygous mutants displayed posterior neural tube, dorsal root ganglion, and optic defects, and were embryo-lethal by E13.5.
In this study, we describe a new null Fkbp8 mouse mutant that is not embryo-lethal. More importantly, this mutant allele displays similar clinical features of human spina bifida, including cystic protrusion at the thoracico-lumbo-scaral region with a dysplastic spinal cord, and vertebrae arches which failed to fuse at the dorsal midline, as well as lower body paralysis.
Phenotypic analysis revealed that the Fkbp8 mutants have a dilated neural tube. In addition, these mutants exhibit patterning defects and increased apoptosis in the neural tube. Gene expression analysis revealed primarily perturbation of expression of several neural tube patterning genes in the mutants. Overall, these studies demonstrate that the Fkbp8 gene is not critical for embryo survival, but it is essential for spinal neural tube patterning, and to inhibit cell death in the developing neural tube. The new Fkbp8 mutant allele is a valuable experimental mouse model which will be useful in dissecting the etiology and pathogenesis of spinal neural tube defects in humans.
RESULTS

Identification of the new Fkbp8
Gt(neo) null allele in mouse
The previously targeted Fkbp8 mutant has a severely dilated posterior neural tube and the homozygous mutants are embryo-lethal by E13.5 (13) . We discovered a gene trapped Fkbp8 allele that produced a milder phenotype, resulting in mice that showed posterior NTD typical of spina bifida, but survived up to five months of age. Sequence comparison with genomic Fkbp8 revealed that the gene trap had inserted into the first intron at nucleotide position 1085, which is 666bp upstream of the ATG (Fig. 1A) . A PCR genotyping assay was performed to identify the wildtype and gene trapped Fkbp8 alleles which were 442bp and 457bp respectively (Fig. 1B) .
The mouse Fkbp8 gene has three alternate first exons designated as 1a, 1b, and 1c, and four transcript variants generated by alternative promoter usage and mRNA splicing (14) .
We re-mapped the gene trap integration site, which was found to be between the transcriptional start sites of 1b and 1c (Fig. 1A) , suggesting that transcripts 1a and 1b are trapped, while 1c is not. Thus wildtype Fkbp8 mRNA is produced in the gene trapped (Gt) mutants. To verify this and also to characterize the different transcripts in the wildtype (WT), heterozygous (WT/Gt), and homozygous mutant (Gt/Gt) Fkbp8 embryos, RT-PCR was performed at E9.5 (Fig. 1C ).
Transcript specific PCR of 1a-, 1b-, and 1c-WT amplicons spanned mostly the 5'UTR and part of the ORF. 1a-and 1b-WT were detected in the WT and WT/Gt embryos, but not in the Gt/Gt mutants (Fig. 1C) . Furthermore, the splice acceptor in the neomycin gene (NEO) enabled fusion to the first exon of 1a and 1b, generating 1a-and 1b-NEO transcripts, which were detected only in the WT/Gt and Gt/Gt Fkbp8 mutants, but not in the WT samples (Fig. 1C) . Because the retroviral integration occurred upstream of the transcriptional start site of 1c, we asked if 1c-WT transcripts were present in Gt-containing embryos. Surprisingly, 1c-WT was present in the WT and WT/Gt embryos, but was barely detectable in the Gt/Gt mutants (Fig. 1C) . Examination of Fkbp8 mRNA including exons 3 to 6 and 6 to 10 revealed the same result, suggesting that either no or very little wildtype Fkbp8 mRNA was present in the Gt/Gt Fkbp8 mutants (Fig. 1C ).
This was substantiated by the absence of Fkbp8 mRNA in Gt/Gt Fkbp8 mutants as determined by wholemount in situ hybridization at E8.5 to E11 (Fig. 2C -E and data not shown).
We next validated our RT-PCR results with quantitative real-time PCR using E9.5 and E10.5 total RNA ( Fig. 2A) . While Fkbp8 mRNA was clearly detected in the WT, and to a lesser extent in the WT/Gt embryos, it was reduced to background levels in the Gt/Gt mutants ( Fig. 2A; n>3 embryos per genotype, ***P <0.0001 by Student's t-test). To examine if wildtype FKBP8 protein levels were also reduced, we probed E9.5 protein extracts with an anti-FKBP8 antibody.
As shown in Fig. 2B , while FKBP8 protein was clearly detected in the WT and WT/Gt embryos, it was absent in the Gt/Gt mutants. Taken together, the fact that neither Fkbp8 mRNA nor protein could be detected in the Gt/Gt Fkbp8 mutant clearly indicates that this mutant represents a null allele of the mouse Fkbp8 gene, and is designated as Fkbp8 Gt(neo) allele.
Mouse Fkbp8 gene is not required for embryo survival but has an essential role for posterior neural tube development
The Gt/Gt Fkbp8 Gt(neo) mutants are live-born, and survive through postnatal stages.
Morphological examination at E18.5 revealed that all mutant fetuses present with an isolated spina bifida, which spans the thoracic and lumbar region (arrow in Fig. 3E ). The defect is characterized by a skin-covered cystic protrusion containing a dysplastic spinal cord and cleft spine (insert in Fig. 3E ). At birth, the mutant mice are not significantly different from their littermates in terms of body weight. As post-natal life progresses, the Fkbp8 Gt(neo) mutants develop splayed hind limbs (arrows in Fig. 3F ) and lower body paralysis. These mutants have great difficulty ambulating, which might hamper their ability to be adequately nursed. Possibly due to lack of nutrition, the mutants are smaller in size and the size difference relative to the unaffected littermates becomes increasingly evident with continued postnatal development. As shown in Fig. 3F , the mutant is one-third the size of its wildtype littermate.
The spinal cord abnormality in the Gt/Gt Fkbp8 Gt(neo) mice is evident at E10.5, with an edema posterior to the forelimb bud and extending to the caudal region (arrow in Fig. 3B ). At E9.5, the posterior neural tube in the mutant appears normal (Fig. 3A) . Between the stages of E11.5 and E13.5, the posterior neural tube dilates even more (Fig. 3C) . From E14.5 onwards, the dilation subsides and the skin-covered defect contains protruded neural tissue which can be seen from the thoracic to the lumbosacral region (arrow in Fig. 3D and data not shown).
Analysis of tissue sections of E11.5 Gt/Gt Fkbp8 Gt(neo) and wildtype fetuses revealed that the mutant neural tube at the lumbar region was only half the thickness of that in wildtype (Fig.   4C ). Moreover, the dorsal root ganglia were smaller and disorganized in the mutant (arrows in Fig. 4C, D) . At the cervical and thoracic level, the overall neural tube morphology did not differ significantly ( Fig. 4A and data not shown). At E15.5, the mutant spinal cord at the thoracic level is significantly larger than that of the wildtype, and it lacks the 'butterfly' characteristics of a normally differentiated spinal cord (compare Fig. 4E to F). There are expansion and folding of the spinal cord which worsen towards the caudal axis (insert in Fig. 3D ). At the lumbar region, the mutant spinal cord shows no distinct distribution of gray and white matter. There is also discontinuity in the spinal cord thickness; the ventral aspect being thinner as compared to the lateral and dorsal regions (Fig. 4G ).
At E18.5, the Gt/Gt Fkbp8 Gt(neo) mutants displayed a drastically stretched spinal cord at the thoracic level (Fig. 4I) . Unlike the wildtype, the mutant spinal cord per se has no distinct marginal layer, and lacks ventral and dorsal grey horns (compare Fig. 4I to J). The cartilage primordia of the vertebral arches are not fused (asterisk in Fig. 4I ), and the spinal cord is covered only by the skin. By comparison, the spinal cord in wildtype fetuses is completely protected by the over and underlying vertebrae (asterisk in Fig. 4J ). At the lumbar region of the mutants, the skin is reduced to a thin layer and overlying very little spinal tissue (arrows in Fig.   4K ). In contrast to the vertebral structure developing around and protecting the wildtype spinal cord, the underlying vertebra in the mutant is flattened (asterisks in Fig. 4K Fig. 5E ). In contrast to the well-separated vertebral centers in the wildtype fetuses, the vertebral centers in the Gt/Gt Fkbp8 gt(neo) mutants are irregular, and are fused between consecutive vertebrae (asterisks in Fig. 5E, F) . In addition, the cartilaginous part of the lumbar and sacral vertebrae is completely fused, forming a lumbosacral cartilage (dotted line in Fig. 5E , and compare to Fig. 5F ). In the Gt/Gt Fkbp8 gt (neo) mutants, the last thoracic and all lumbar vertebrae are the most affected region of the spinal column, and these vertebral abnormalities are completely absent in the cervical region.
Endogenous FKBP8 activity prevents apoptosis in the posterior neural tube
As shown in HeLa and Huh7 cells, siRNA knockdown of Fkbp8 led to increased apoptosis (15, 16) . FKBP8 inhibits apoptosis through its interaction with anti-apoptotic proteins such as BCL2
and BCL-XL, and targeting these proteins to the mitochondria (15, 17) . We questioned whether in vivo FKBP8 possesses anti-apoptotic functions, and if its deficiency leads to increased cell death in Gt/Gt Fkbp8 Gt(neo) mutants. To this end, we performed TUNEL staining on tissue sections prepared from wildtype and mutant embryos, and quantified the number of TUNELpositive cells. At E9.5 when the neural tube lumen was slightly enlarged in the mutant embryo, the number of TUNEL-positive cells (arrows in Fig. 6A , B) in the neural tube was comparable between wildtype and mutant embryos when analyzed at the lumbar levels ( Fig. 6G) . At E10, the number of TUNEL-positive cells increased dramatically in the mutant neural tube, and was over two-fold higher than that in the wildtype (Fig. 6C, D However, E10 or E10.5 mutant embryos displayed intense staining in the caudal region ( compare intensities between O and P). The NBS staining also revealed an irregular neural tube at the level of and caudal to the forelimb bud (arrowheads in Fig. 6M ), which was absent in the wildtype (Fig. 6N ). The staining intensity at this region was however similar to that in the wildtype but was weaker than that in the caudal axis of the mutants (see dotted red line indicating boundary in Fig. 6M ). Results from our cell death analysis clearly demonstrate that endogenous FKBP8 exhibits anti-apoptotic functions, specifically in the posterior neural tube.
Endogenous FKBP8 activity is required for posterior neural tube patterning
Finally, to identify genes or pathways of gene expression that are affected by the loss of Fkbp8,
we performed microarray analysis using the posterior embryonic region isolated from E9.5 Gt/Gt
Fkbp8
Gt(neo) mutant and wildtype littermates. The dissected tissue included the region caudal to the forelimb bud and extending to the tail region. We chose E9.5 because it is the stage where cell death is not significantly different between both genotypes. This was to eliminate any nonspecific gene expression changes due to apoptosis. The microarray analysis indicated a total of 110 genes with a differential gene expression in the Gt/Gt Fkbp8 Gt(neo) mutants; 71 genes were down-regulated, while 39 genes were up-regulated, and some of these genes were further subcategorized into three Gene Ontology (GO) terms, which included regulation of transcription, signal transduction activity, and cell communication. As shown, most of these genes were expressed in the spinal cord (Table 2) . Fkbp8 was the most down-regulated gene (Table 2) were again harvested and their total RNA was processed for qRT-PCR using Taqman® gene expression assays. Except for Hsf2, the direction (positive/negative regulation) was consistent between the microarray data and qRT-PCR results for the remaining 15 genes, indicating an excellent fidelity of the microarray analysis to identify gene expression changes (Table 3) .
We have previously observed ventralized neural tubes in the Gt/Gt Fkbp8 Gt(neo) mutants, as evidenced by expanded Shh and Ben expression domains at E10.5 (RLY Wong, unpublished data). Consistently, in our microarray analysis, most of the ventral neural tube markers including Nkx2-9, Myt1, FoxA2, and Nkx6-1 were over-expressed in the mutants (Tables 2, 3 ). In parallel, dorsal neural tube markers such as Zic1, and Scube2, were under-expressed (Tables 2, 3 ). In situ expression analysis at E10 or E10.5 indicated an up-regulation of the Shh gene in the mutant neural tube (data not shown), but it was only slightly over-expressed at E9.5, as indicated by microarray analysis (Table 3) . Further examination using KEGG pathway analysis revealed a moderate increase in the expression of Shh pathway genes such as Ptch1, Smo,
and Glis, in the mutants (data not shown). Gene expression changes of other transcriptional regulators in the mutants were also noted, which included up-regulation of pro-neuronal differentiation genes such as Neurod4, Lhx2, and Myt1 (Tables 2, 3 ) (19-21). In parallel, the mouse Hes3 gene, which has been shown to be an antagonist for neuronal differentiation (22), was down-regulated (Tables 2, 3 ). To further verify that the gene expression changes could indeed be detected in vivo, we collected E9.5 wildtype and mutant embryos and performed in situ hybridization with FoxA2, Nkx2-9, and Hes3 probes. In the mouse, FoxA2 is expressed in the floor plate and notochord at E9.5 (23) (Fig. 7A ). Nkx2-9, on the other hand, is expressed in the ventral domain of neuronal progenitors that give rise to V3 interneurons (24) (Fig. 7A ). Hes-region ( Fig. 7A ). These results further substantiate the notion that the Gt/Gt Fkbp8 Gt(neo) mutants have primarily neural tube patterning defects, which might contribute to the differentiation defects observed in the mutant spinal cords at later stages.
We next questioned if any of the known spina bifida genes were under-expressed in our microarray data. Fgfr1, Itgb1, Lrp6, Msx1, Rab23, and Zic2 were only mildly down-regulated, while Zic1 was the most under-expressed amongst this panel of genes. In the mouse Zic1 knockout, the dorsal horn mass was decreased in the thoracic spinal cord at E15.5 (26). We reexamined Gt/Gt Fkbp8 Gt(neo) mutant spinal cords at E15.5 and found a smaller dorsal horn mass at the thoracic region; a phenotype similar to that of Zic1 mutant phenotype (Fig. 4E ). In both zebrafish and mouse Zic1 loss-of-function mutants, the vertebral arches did not fuse along the dorsal midline. Additionally, the spinous processes, which arise from the most dorsal part of the vertebral arches, were also missing (27, 28). These skeletal deformities were highly similar to that seen in our Gt/Gt Fkbp8 Gt(neo) mutants (Fig. 5A ). In our Gt/Gt Fkbp8 Gt(neo) mutants, Zic1 was down-regulated by -4.49 fold (***P <0.0001) as determined by qRT-PCR analysis (Table 3) . We examined endogenous Zic1 expression in WT and Gt/Gt Fkbp8 Gt(neo) mutant embryos at E9.5
and found that in the mutants, Zic1 expression was indeed down-regulated not only in the neural tube, but also in the somites (arrowheads in Fig. 7B ). Analysis of E10 embryos revealed similar results in the Gt/Gt Fkbp8 Gt(neo) mutants, although under-expression in the somites was not as significant compared to that at E9.5. (Fig. 7B) . It is possible that the spinal cord and vertebral arch abnormalities seen in the Gt/Gt Fkbp8 Gt(neo) mutants could be due, in part, to the diminished expression of Zic1 in the dorsal neural tube and somites.
DISCUSSION
In this study, we present the phenotypic and molecular characterization of a new Fkbp8 In the targeted Fkbp8 mutants, the most striking phenotype is the dilated neural tube (13) . We have observed an identical neural tube phenotype in our Fkbp8 Gt(neo) mutants, these mutants have a dilated posterior neural tube, and neural tube patterning defects.
While it is likely that excessive Shh signaling is responsible for the cell death and patterning defects in the Gt/Gt Fkbp8 Gt(neo) mutants, it remains unresolved whether Shh over-expression alone is sufficient to induce the dilated posterior neural tube defect.
The conventional rescue regime for mouse NTDs is through maternal folic acid or inositol supplementation (44, 45) . We questioned if the spina bifida phenotype in the Gt/Gt mutants could be rescued through maternal supplementation with these agents. Unfortunately, neither folic acid nor inositol had any effect on lowering either the occurrence, or severity of spina bifida in the mutant fetuses ( we have demonstrated the important roles of FKBP8 in neural tube patterning, and blocking apoptosis in the developing posterior neural tube. Understanding abnormal gene function at the cellular and molecular levels provides an entry point in efforts to find appropriate intervention strategies to prevent the occurrence of these devastating birth defects.
MATERIALS AND METHODS
Generation and genotyping of mutant Fkbp8 Gt(neo) mice and Drug rescue
The ES cell clone OST287985 containing a gene trap insertion in the Fkbp8 gene was identified from the Omnibank database from Lexicon Pharmaceuticals Inc. (The Woodlands, TX), and microinjected into C57BL/6 blastocysts to generate germline chimeras. Chimeric males were bred to C57BL/6 females for germ line transmission. Animal experimentation was approved by the IBT Animal Care Committee. Mice used in this study were of mixed 129/C57 background.
Either tail or yolk sac genomic DNA was extracted and used for genotyping (Primer sequences in 
Histological and skeletal analysis, in situ hybridization, and cell death analysis
WT and Gt/Gt Fkbp8 Gt(neo) fetuses from various stages were harvested, fixed and processed for standard histological analysis. E18.5 WT and Gt/Gt Fkbp8 Gt(neo) fetuses were subjected to bone and cartilage staining, which was performed according to previously described methods but with minor modifications (46) . Double stained skeletons were examined under a Leica MZ 95 stereomicroscope and digital pictures were taken (Leica Microsystems Digital Camera DFC480, Wetzlar, Germany). Skeletal abnormalities were scored according to published methods (47) .
To detect Fkbp8 mRNA, an image clone 3601511 which contains the full length mouse analysis with Benjamin Hochberg correction was applied, and following selection criteria of fold change ≥ 1.7 and P value <0.05 to filter out significant changes. Z-scores were calculated to indicate the statistical significance of detecting the differentially expressed genes with Gene Ontology (GO) terms, and a score of ≥2 or ≤-2 was considered statistically significant.
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